Tag:
Texas
Latest Headlines
Latest Headlines
Texas rustles Dana-Farber science team to spearhead $75M cancer R&D effort
With an eye to ramping up some ambitious new R&D work on a new generation of cancer therapies, Houston's renowned MD Anderson Cancer Center has poached 55 scientists from the equally well known
Texas' top court nixes $32M Vioxx award
Merck ( $MRK ) won a reversal of the $32 million jury verdict in a Texas case over the Vioxx painkiller. The state's Supreme Court decided that the family of Leonel Garza didn't produce enough evidence
Perry-for-president disavows HPV vax mandate
Texas Gov. Rick Perry courted controversy 6 years ago with an executive order mandating that 6th-grade girls get an anti-HPV shot. Perry withstood catcalls from conservative lawmakers and voters, not
Cancer drug upstart adds $18M in venture cash to state grant
Dallas-based cancer drug upstart Peloton Therapeutics has rounded up an $18 million Series A to finance its development work on a group of compounds identified in labs at UT Southwestern. And the
U.S. Army reopens doc payment investigation
Now that a $25 million settlement with Novo Nordisk has closed, the U.S. Army has restarted its probe of improper doctor payments at Fort Sam Houston in San Antonio. The Army is keeping its mouth
J&J faces trial in $1B Risperdal influence case
A Texas jury is set to consider allegations that Johnson & Johnson's Janssen unit used false advertising, grants, junkets and other perks to persuade state officials to give its Risperdal
Failed Texas biotech exec gains from state tech fund
One of the beneficiaries of the Texas Emerging Technology Fund has been David Nance, who started the biotech company Introgen Therapeutics and helped raise more than $700 million from investors
Texas kicks in for vegan vaccine funding
Oddly in line with last week's federal announcement setting in motion a medical countermeasures makeover in the U.S., the state of Texas is awarding $4 million for a production center that aims to
Bankrupt Introgen operations revived as CMO
A group of Houston investors have transformed the defunct operations of Introgen Therapeutics into a contract manufacturing organization. The Austin-based biotech was in the midst of bankruptcy
UT prof didn't report even more Glaxo cash
The amount of undisclosed cash paid a University of Texas researcher may be some 50 percent bigger than we originally thought. According to a new letter from Sen. Charles Grassley to the university,
